Interleukin-1β induces trained innate immunity in human hematopoietic progenitor cells in vitro

Stem Cell Reports. 2024 Dec 10;19(12):1651-1664. doi: 10.1016/j.stemcr.2024.09.004. Epub 2024 Nov 7.

Abstract

Innate immune cells can develop a long-lasting hyperresponsive phenotype, termed trained immunity, mediated by epigenetic and metabolic reprogramming. In mice, exposure to Bacille Calmette-Guérin (BCG), β-glucan, or Western diet induces trained immunity by reprogramming hematopoietic progenitor cells (HPCs), through interleukin-1β (IL-1β) signaling in the bone marrow (BM). We investigated whether IL-1β induces trained immunity in primary human BM-derived HPCs in vitro. We exposed human BM-derived HPCs to IL-1β for 4 h. HPCs were expanded and differentiated into monocytes followed by functional and transcriptomic characterization. IL-1β-exposed HPCs showed higher granulocyte-macrophage colony-forming units. The monocyte offspring produced more tumor necrosis factor (TNF) and IL-1β after restimulation with lipopolysaccharide (LPS) and Pam3Cys and is metabolically more active. Transcriptomic analysis showed upregulation of key atherogenic and inflammatory pathways. In conclusion, brief exposure of human BM-derived HPCs to IL-1β in vitro induces a trained immunity phenotype.

Keywords: IL-1β; bone marrow; hematopoietic progenitor cells; macrophages; monocytes; trained immunity.

MeSH terms

  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Gene Expression Profiling
  • Hematopoietic Stem Cells* / cytology
  • Hematopoietic Stem Cells* / drug effects
  • Hematopoietic Stem Cells* / metabolism
  • Humans
  • Immunity, Innate* / drug effects
  • Interleukin-1beta* / metabolism
  • Lipopolysaccharides* / pharmacology
  • Monocytes / drug effects
  • Monocytes / immunology
  • Monocytes / metabolism
  • Trained Immunity
  • Transcriptome
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-1beta
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha